BLUE - bluebird bio, Inc.

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Currency in USD
Earnings estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts11111110
Avg. Estimate-0.74-0.67-1.97-1.68
Low estimate-0.9-0.96-2.7-2.5
High estimate-0.6-0.48-1.33-1.27
Year ago EPS-1.36-0.94-3.39-1.97
Revenue estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts881111
Avg. Estimate11.77M16.74M53.07M144.98M
Low estimate6.3M9M32.8M68.75M
High estimate20M27.4M85.12M385.88M
Year ago sales1.52M1M3.6M53.07M
Sales growth (year/est)674.90%1,574.00%1,375.40%173.20%
Earnings history29/06/202229/09/202230/12/202230/03/2023
Est. EPS-1.24-1.12-0.44-0.37
Actual EPS-1.36-0.940.380.21
Difference-0.120.180.820.58
Surprise %-9.70%16.10%186.40%156.80%
EPS trendCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Current estimate-0.74-0.67-1.97-1.68
7 days ago-0.73-0.68-1.98-1.59
30 days ago-0.69-0.62-2.21-1.6
60 days ago-0.67-0.62-2.17-1.6
90 days ago-0.68-0.65-2.52-1.74
EPS revisionsCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days4474
Down last 7 daysN/AN/AN/AN/A
Down last 30 days1111
Growth estimatesBLUEIndustrySector(s)S&P 500
Current qtr.45.60%N/AN/AN/A
Next qtr.28.70%N/AN/AN/A
Current year41.90%N/AN/AN/A
Next year14.70%N/AN/AN/A
Next 5 years (per annum)45.80%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A